{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02032",
      "entity_text" : "nuclear factor-kappaB ligand",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04543",
      "entity_text" : "fraxetin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In addition, fraxetin was demonstrated to suppress receptor activator of nuclear factor-kappaB ligand (RANKL)-mediated osteoclast differentiation and bone resorption in vitro in a dose dependent manner.",
  "reading_complete" : "2020-08-03T17:37:34Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:36:57Z",
  "trigger" : "suppress",
  "evidence" : [ "fraxetin was demonstrated to suppress receptor activator of nuclear factor-kappaB ligand" ],
  "pmc_id" : "6089765",
  "score" : 0
}